Page results
-
The maternity team at UCLH will listen to your hopes and concerns and can suggest helpful and practical ideas to help you.
-
The service offers psychotherapeutic intervention for women receiving ante-natal and post-natal care at UCLH, their partners, and their children in the event of perinatal loss.
-
This information is for patients who are receiving radiotherapy to the prostate or prostate bed. It explains what the treatment involves, describes side-effects you may experience during and after treatment, and how best to cope with them.
-
Radiotherapy Department Patient Information series no. 18 - prostate brachytherapy prostate high dose rate (HDR) brachytherapy
-
The molecular genetics laboratory at UCLH is a national centre for the genetic diagnosis of haemoglobin disorders, including prenatal diagnosis.
-
The lung function unit is an integral part of the department of Thoracic Medicine, offering a wide range of physiological tests to both inpatients and clinic outpatients within the Trust, to help not only in the diagnoses of lung disorders, but also to assess the severity of these conditions.
-
The department of Thoracic Medicine at UCH has particular expertise in the management of patients with bronchiectasis and respiratory infections (including fungal disease, lung abscess and opportunistic infections).
-
This page provides information for patients visiting the Inflammatory Bowel Disease clinic.
-
This information outlines the things that you need to take home after your robotic prostatectomy.
-
Myeloproliferative neoplasms (MPN) are disorders that affect how the body produces red blood cells, white blood cells, and platelets.
File results
-
FOI/2024/0401 - Hospital treatments for abortion complications
-
FOI/2024/0402 - Various IT systems used at the Trust
-
FOI/2024/0403 - Risk Policy and corporate risk register
-
FOI/2024/0406 - Staff and patient discrimination complaints in 2021, 2022 and 2023
-
FOI/2024/0409 - Number of A&E attendees with mental health complaints from 2022 to 2024
-
FOI/2024/0412 - Healthcare travel costs scheme for patients
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine
-
FOI/2024/0416 - Home dialysis treatment
-
FOI/2024/0417 - Funding for point-of-care home blood monitoring devices for cancer patients
-
FOI/2024/0420 - Commercialisation of NHS patient data